Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06489288 | ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer | unknown | N/A | 2,656 | Xijing HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT01638130 | Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers | unknown | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03079323 |
| Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer(PART) |
| unknown |
| Phase 2 |
| 137 |
| Universitaire Ziekenhuizen KU LeuvenOTHER |
| 1 |
| Jul 3, 2024 |
| clinicaltrials |
| NCT03080116 | Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy(ARNEO) | unknown | Phase 2 | 90 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03327675 | High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer | unknown | N/A | 188 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03340376 | Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer | unknown | Phase 2 | 48 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03784066 | Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity(DUTRELASCO) | unknown | Phase 1 / Phase 2 | 21 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03819751 | MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection(PROSOVI) | unknown | N/A | 96 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03885648 | Breast Cancer and Its Relationship With the Microbiota(MICROMA) | unknown | — | 150 | Universidad de GranadaOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT04562337 | SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC | unknown | Phase 2 | 67 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT04654975 | Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)(METABREC) | unknown | — | 10,000 | Universitaire Ziekenhuizen KU LeuvenOTHER | 6 | Jul 3, 2024 | clinicaltrials |
| NCT04990076 | Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology(MUSA1) | unknown | — | 1,500 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05229003 | Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC | unknown | Phase 2 | 44 | Fudan UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05610501 | Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. | unknown | — | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 4 | Jul 3, 2024 | clinicaltrials |
| NCT05797454 | Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer | unknown | N/A | 170 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05838001 | Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neoadjuvant Therapy | unknown | N/A | 110 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05847348 | 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients | unknown | Phase 3 | 110 | Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06090656 | Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)(BEST) | unknown | Phase 2 | 88 | Sun Yat-sen UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06482281 | COVID-19 and Childhood Cancer | unknown | — | 100,000 | Karolinska InstitutetOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06483685 | Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of Safety(RADIANTS) | unknown | — | 500,000 | University Hospital, CaenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06483919 | The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer | unknown | — | 228 | Jinming YuOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06484361 | PET/MRI to Stage Prostate Cancer Patients | unknown | Phase 2 | 50 | IRCCS San RaffaeleOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06485557 | A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC | unknown | Phase 3 | 90 | Tang-Du HospitalOTHER | 0 | Jul 3, 2024 | clinicaltrials |
| NCT06485713 | Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC | unknown | Phase 2 | 200 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06485869 | Impact of Virtual Reality on the Quality of Life of Oncology Patients(VIRONSCARE) | unknown | N/A | 150 | Central Hospital Saint QuentinOTHER_GOV | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06486220 | PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial. | unknown | Phase 3 | 96 | Yun-fei XiaOTHER | 0 | Jul 3, 2024 | clinicaltrials |
| NCT06486350 | IL-6: A Marker for AML Chemo Sensitivity | unknown | — | 72 | Fujian Medical University Union HospitalOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT01284153 | Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study | unknown | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT01346020 | Genomic Analysis of Patients With Chronic Lymphocytic Leukemia | unknown | — | 53 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT02628405 | R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma | unknown | Phase 1 / Phase 2 | 30 | Academic and Community Cancer Research UnitedOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT04397978 | Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases(LAT-MUM) | unknown | — | 180 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT04807114 | A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC | unknown | — | 70 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT05008497 | Cancer and Literacy in Health(CaLiS) | unknown | — | 1,300 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT05606848 | To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer | unknown | N/A | 350 | Fresenius Kabi Sino-Swed Pharmaceutical Corp. LtdINDUSTRY | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06456112 | Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV | unknown | — | 83 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06456281 | Multi-omics Model for Pancreatic Cancer Screening Using cfDNA | unknown | — | 480 | Fudan UniversityOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06479005 | ETERNALS: Remote Monitoring in Lung Cancer Patients(ETERNALS) | unknown | N/A | 50 | Ziekenhuis Oost-LimburgOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06481332 | Diagnostic Characterization and Evolution of "Triple Negative" Thrombocytosis (CASTETTE)(CASTETTE) | unknown | — | 300 | University Hospital, BrestOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06481345 | Characterization of Myeloproliferative Neoplasia With a Mutated IDH, SRSF2 or SF3B1 Allele (CARPEDIEM)(CARPEDIEM) | unknown | — | 300 | University Hospital, BrestOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06481449 | Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study | unknown | — | 2,600 | Hebei Medical University Fourth HospitalOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06481527 | Seen and Be Heard: Ensuring Fair Cancer Care for All Children | unknown | — | 50 | Great Ormond Street Hospital for Children NHS Foundation TrustOTHER | 0 | Jul 1, 2024 | clinicaltrials |
| NCT06481553 | RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody | unknown | — | 480 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06481605 | A Novel Adaptive Anastomotic Technique for Left-sided Colonic and Rectal Resection(NOVA) | unknown | N/A | 30 | Istituto Clinico HumanitasOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06482008 | HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study | unknown | Phase 2 | 33 | Sun Yat-sen UniversityOTHER | 0 | Jul 1, 2024 | clinicaltrials |
| NCT04896684 | Chronic Intestinal Pathologies Analytical Cohort at TouLouse(CAPITOL) | unknown | — | 300 | University Hospital, ToulouseOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT04939883 | Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy(CardioTox) | unknown | Phase 4 | 1,018 | Hospital Sirio-LibanesOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT05677022 | Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast Cancer(APECS) | unknown | N/A | 60 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06118229 | A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients | unknown | — | 300 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06479759 | LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer(ACCLAIM) | unknown | Phase 2 | 50 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jun 28, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jul 5, 2024source: clinicaltrials